From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.14
First Reported 1992
Last Reported 2009
Negated 0
Speculated 0
Reported most in Abstract
Documents 3
Total Number 3
Disease Relevance 2.18
Pain Relevance 0.35

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

plasma membrane (Slc11a1) molecular_function (Slc11a1) cellular_component (Slc11a1)
biological_process (Slc11a1) lysosome (Slc11a1)
Anatomy Link Frequency
urine 1
Slc11a1 (Rattus norvegicus)
Pain Link Frequency Relevance Heat
interstitial cystitis 4 99.50 Very High Very High Very High
anesthesia 1 76.92 Quite High
Eae 1 5.00 Very Low Very Low Very Low
Pain 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Interstitial Cystitis 4 99.50 Very High Very High Very High
Disease Progression 3 99.20 Very High Very High Very High
Recurrence 17 97.96 Very High Very High Very High
Cancer 24 97.80 Very High Very High Very High
Carcinoma In Situ 52 94.40 High High
Fever 16 85.04 High High
Toxicity 2 78.48 Quite High
Bladder Cancer 4 75.00 Quite High
Carcinoma 3 52.68 Quite High
Disease 5 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Immunotherapy, as exemplified by Bacillus Calmette-Guérin (BCG), has achieved better results: long-term reduction in tumor recurrence, reduction in disease progression and prolongation of patient survival.
BCG Binding (exemplified) of associated with cancer, disease progression and recurrence
1) Confidence 0.14 Published 1992 Journal Anticancer Drugs Section Abstract Doc Link 1611116 Disease Relevance 0.99 Pain Relevance 0.08
Intravesical approaches have failed, such as valrubicin [9], are investigational, such as gemcitabine [10] and mycobacterial cell wall preparations [11], or efficacy should be confirmed, such as the combination of BCG and interferon-alpha 2b [12].
BCG Binding (combination) of
2) Confidence 0.01 Published 2009 Journal World J Urol Section Body Doc Link PMC2694311 Disease Relevance 0.92 Pain Relevance 0
We measured candidate urine biomarkers and bladder cell DNA cytometry in interstitial cystitis (IC) patients randomized to receive intravesical Bacillus Calmette Guerin (BCG) or placebo in a multicenter trial.
BCG Binding (receive) of in urine associated with interstitial cystitis
3) Confidence 0.01 Published 2007 Journal World J Urol Section Abstract Doc Link 17694391 Disease Relevance 0.27 Pain Relevance 0.27

General Comments

This test has worked.

Personal tools